Competition in Biofilms between Cystic Fibrosis Isolates of Is Shaped by R-Pyocins.

is an opportunistic pathogen and the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. infections are difficult to treat due to a number of antibiotic resistance mechanisms and the organism's propensity to form multicellular biofilms. Epidemic strains of often dominate within the lungs of individual CF patients, but how they achieve this is poorly understood. One way that strains of can compete is by producing chromosomally encoded bacteriocins, called pyocins. Three major classes of pyocin have been identified in : soluble pyocins (S types) and tailocins (R and F types). In this study, we investigated the distribution of S- and R-type pyocins in 24 clinical strains isolated from individual CF patients and then focused on understanding their roles in interstrain competition. We found that (i) each strain produced only one R-pyocin type, but the number of S-pyocins varied between strains, (ii) R-pyocins were generally important for strain dominance during competition assays in planktonic cultures and biofilm communities in strains with both disparate R- and S-pyocin subtypes, and (iii) purified R-pyocins demonstrated significant antimicrobial activity against established biofilms. Our work provides support for a role played by R-pyocins in the competition between strains and helps explain why certain strains and lineages of dominate and displace others during CF infection. Furthermore, we demonstrate the potential of exploiting R-pyocins for therapeutic gains in an era when antibiotic resistance is a global concern. A major clinical problem caused by , is chronic biofilm infection of the lungs in individuals with cystic fibrosis (CF). Epidemic strains dominate and displace others during CF infection, but these intraspecies interactions remain poorly understood. Here we demonstrate that R-pyocins (bacteriocins) are important factors in driving competitive interactions in biofilms between strains isolated from different CF patients. In addition, we found that these phage-like pyocins are inhibitory against mature biofilms of susceptible strains. This highlights the potential of R-pyocins as antimicrobial and antibiofilm agents at a time when new antimicrobial therapies are desperately needed.